Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment of refractory esophageal Crohn's disease with infliximab.

Literature DB >> 11508675

Successful treatment of refractory esophageal Crohn's disease with infliximab.

D S Fefferman, S A Shah, M Alsahlil, A Gelrud, K R Falchulk, R J Farrell.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2001 PMID： 11508675 DOI： 10.1023/a:1010613823223

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

13 in total

1. Infliximab for the treatment of fistulas in patients with Crohn's disease.

Authors: D H Present; P Rutgeerts; S Targan; S B Hanauer; L Mayer; R A van Hogezand; D K Podolsky; B E Sands; T Braakman; K L DeWoody; T F Schaible; S J van Deventer
Journal: N Engl J Med Date: 1999-05-06 Impact factor: 91.245

2. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

Authors: G D'haens; S Van Deventer; R Van Hogezand; D Chalmers; C Kothe; F Baert; T Braakman; T Schaible; K Geboes; P Rutgeerts
Journal: Gastroenterology Date: 1999-05 Impact factor: 22.682

3. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors: S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal: N Engl J Med Date: 1997-10-09 Impact factor: 91.245

Successful treatment of refractory esophageal Crohn's disease with infliximab.

1. Infliximab for the treatment of fistulas in patients with Crohn's disease.

2. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

3. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

4. Endoscopic results in five patients with Crohn's disease of the esophagus.

5. Roentgenologic features of regional enteritis of the upper gastrointestinal tract.

6. Treatment of severe esophageal Crohn's disease with infliximab.

7. Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

8. The natural history of esophageal Crohn's disease: three patterns of evolution.

Review 9. Esophagogastric fistula: a complication of Crohn's disease--case report and review of the literature.

10. Crohn's disease of the esophagus.

1. Crohn's Disease: Hard to Swallow!

2. Crohn's disease of the esophagus.

3. Esophageal Crohn's disease treated "topically" with swallowed aerosolized budesonide.

4. Perioperative adjuvant therapy with infliximab in complicated anal Crohn's disease.